13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...9, 10, 11, 12, 13, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-04-18
4:49 pm
Purchase
2022-04-05 13D MoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P 21,751,284
58.900%
21,751,284increase
(New Position)
Filing
History
2022-04-04
4:38 pm
Purchase
2022-03-25 13G AN2 Therapeutics, Inc.
ANTX
BIOTECHNOLOGY VALUE FUND L P 1,616,665
8.600%
1,616,665increase
(New Position)
Filing
History
2022-03-24
4:22 pm
Purchase
2022-03-14 13G Tyra Biosciences, Inc.
TYRA
BIOTECHNOLOGY VALUE FUND L P 2,472,327
5.900%
2,472,327increase
(New Position)
Filing
History
2022-03-18
7:18 pm
Sale
2021-12-31 13G Xenon Pharmaceuticals Inc.
XENE
BIOTECHNOLOGY VALUE FUND L P 4,305,540
8.200%
-851,946decrease
(-16.52%)
Filing
History
2022-03-14
4:48 pm
Purchase
2022-03-03 13G Arcus Biosciences, Inc.
RCUS
BIOTECHNOLOGY VALUE FUND L P 3,960,948
5.600%
1,208,726increase
(+43.92%)
Filing
History
2022-02-14
2:01 pm
Sale
2021-12-31 13G Infinity Pharmaceuticals, Inc.
INFIQ
BIOTECHNOLOGY VALUE FUND L P 6,353,645
7.100%
-2,030,000decrease
(-24.21%)
Filing
History
2022-02-14
1:56 pm
Purchase
2021-12-31 13G Pieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P 92,583
9.990%
22,563increase
(+32.22%)
Filing
History
2022-02-14
1:53 pm
Purchase
2021-12-31 13G Xenon Pharmaceuticals Inc.
XENE
BIOTECHNOLOGY VALUE FUND L P 5,157,486
9.990%
1,658,140increase
(+47.38%)
Filing
History
2022-02-14
1:51 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
BIOTECHNOLOGY VALUE FUND L P 2,202,315
9.990%
2,202,315increase
(New Position)
Filing
History
2022-02-14
1:49 pm
Purchase
2021-12-31 13G PHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P 51,192
16.500%
10,372increase
(+25.41%)
Filing
History
2022-02-14
1:46 pm
Purchase
2021-12-31 13G Elevation Oncology, Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P 1,611,698
6.900%
1,611,698increase
(New Position)
Filing
History
2022-02-14
1:43 pm
Purchase
2021-12-31 13G ESSA Pharma Inc.
EPIX
BIOTECHNOLOGY VALUE FUND L P 4,565,242
9.990%
859,953increase
(+23.21%)
Filing
History
2022-02-14
1:41 pm
Sale
2021-12-31 13G AC Immune S.A.
ACIU
BIOTECHNOLOGY VALUE FUND L P 7,062,379
9.700%
-854,279decrease
(-10.79%)
Filing
History
2022-02-14
1:38 pm
Purchase
2021-12-31 13G Cogent Biosciences, Inc.
COGT
BIOTECHNOLOGY VALUE FUND L P 3,114,532
7.500%
282increase
(+0.01%)
Filing
History
2022-02-14
1:35 pm
Purchase
2021-12-31 13G Ikena Oncology, Inc.
IKNA
BIOTECHNOLOGY VALUE FUND L P 1,798,371
5.000%
198,713increase
(+12.42%)
Filing
History
2022-02-14
1:33 pm
Purchase
2021-12-31 13G Viracta Therapeutics, Inc.
VIRX
BIOTECHNOLOGY VALUE FUND L P 3,731,744
9.900%
3,731,744increase
(New Position)
Filing
History
2022-02-14
1:30 pm
Purchase
2021-12-31 13G Molecular Templates, Inc.
MTEM
BIOTECHNOLOGY VALUE FUND L P 225,307
6.000%
41,232increase
(+22.40%)
Filing
History
2022-02-14
1:27 pm
Purchase
2021-12-31 13G Spero Therapeutics, Inc.
SPRO
BIOTECHNOLOGY VALUE FUND L P 3,411,520
9.990%
643,242increase
(+23.24%)
Filing
History
2022-02-14
1:23 pm
Purchase
2021-12-31 13G Cullinan Oncology, Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P 5,369,459
12.300%
975,000increase
(+22.19%)
Filing
History
2022-02-14
1:18 pm
Sale
2021-12-31 13G Cartesian Therapeutics, Inc.
RNAC
BIOTECHNOLOGY VALUE FUND L P 57,438
1.500%
-106,766decrease
(-65.02%)
Filing
History
Goto Prev, 0, 1, ...9, 10, 11, 12, 13, ...17, 18, Next